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A B S T R A C T   
This study was undertaken to assess the potential of Non-Starter Lactic Acid Bacteria (NSLAB) from Cheddar 
cheese to survive gastric transit and display probiotic-related traits including bile salt hydrolase activity, the 
ability to adhere to the gut epithelium and inhibition of enteropathogen binding. Populations of NSLAB, up to 
107 CFU/g per cheese were recovered following exposure of cheese to Simulated Stomach Duodenum Passage 
(SSDP) conditions. A total of 240 isolates were randomly selected from twelve Cheddar cheeses and assessed 
probiotic traits. Two strains Lactobacillus paracasei DPC 7150 and Lactobacillus rhamnosus DPC 7102 showed the 
most probiotic potential. The Lb. paracasei and Lb. rhamnosus strains displayed adhesion rates of 64% and 79%, 
respectively and inhibited binding of pathogenic Escherichia coli by >20%. This research demonstrates that 
Cheddar cheese harbours potentially beneficial bacteria, a large portion of which can survive simulated digestion 
and potentially exhibit health beneficial effects once ingested.   
1. Introduction 
Cheese is manufactured using a mixture of four major ingredients 
(milk, rennet, microorganisms and salt), with the assortment of cheese 
types available being a result of variations in this mix, such as the 
concentration of salt used, the source of the milk (cow, sheep or goat’s 
milk) or the actual species of microbes added, together with variations in 
the manufacturing and ripening protocols (Beresford, Fitzsimons, 
Brennan, & Cogan, 2001). While specific microbial cultures, referred to 
as ‘starter’ bacteria, are introduced during cheesemaking for the 
necessary production of acid, this is not the case for all bacteria present 
(Fox, McSweeney, Cogan & Guinee, 2004). Non-starter lactic acid bac-
teria (NSLAB) are microorganisms that grow within cheese during 
ripening but are not deliberately added and are not required for acid 
production in the initial cheese manufacturing process (Beresford, 
2003). The sources of NSLAB include autochthonous milk microbes 
capable of surviving the pasteurisation process and those found in the 
manufacturing plant, with NSLAB populations eventually outcompeting 
the starter cultures and typically reaching between 107 and 109 colony 
forming units (cfu) per gram of cheese at the end of the ripening period 
(Gobbetti, De Angelis, Di Cagno, Mancini, & Fox, 2015). The biochem-
ical reactions undertaken by these NSLAB are responsible for various 
flavour compounds present in maturing cheeses and are, therefore, 
responsible for important organoleptic characteristics of cheese (Set-
tanni & Moschetti, 2010). 
As cheese may contain high NSLAB populations upon ingestion, the 
fate of these microorganisms is of interest due to their ability to 
potentially impact human health or the human gut microbiome. 
Therefore, the capacity of cheese NSLAB populations to survive upper 
gastrointestinal environments should be taken into consideration when 
evaluating health implications of cheese intake. The cheese matrix itself 
has been found to promote survival of deliberately added strains of 
potential probiotic bacteria, providing a buffering effect against acid 
stresses encountered during digestion and supplying a dense, high-fat 
protective barrier for the probiotic strains against the unfavourable 
digestive tract environment (Gomes da Cruz, Alonso Buriti, Batista de 
Souza, Fonseca Faria, & Isay Saad, 2009). Particular attention has been 
focussed on the Lactobacillus genus, which are the dominant NSLAB 
found in Cheddar and most other varieties of long ripened cheese and 
which have also had several strains granted probiotic status (Fijan, 
2014; Swearingen, O’Sullivan, & Warthesen, 2001). Probiotics have 
been defined by the Food and Agricultural Organisation of the United 
Nations (FAO)/World Health Organisation (WHO) as being ‘live mi-
croorganisms, which when consumed in adequate amounts, confer a 
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health benefit on the host’ (Araya, Morelli, Reid, Sanders, & Stanton, 
2002). 
Various in vitro and in vivo assays have been used to determine the 
capability of selected NSLAB strains to survive gastric transit, most of 
which involve the ability to survive acid stress and bile tolerance, as well 
as their potential to express characteristics once within the gut that have 
health benefits for the host (Haller, Colbus, Gänzle, Scherenbacher, Bode 
& Hammes, 2001; Maragkoudakis, Zoumpopoulou, Miaris, Kalantzo-
poulos, Pot & Tsakalidou, 2006; Papanikolaou, Hatzikamari, Georga-
kopoulos, Yiangou, Litopoulou-Tzanetaki & Tzanetakis, 2012). As well 
as bile tolerance, the ability of strains to deconjugate bile via bile salt 
hydrolase (BSH) enzymes is a desirable trait as, as well as potentially 
conferring a competitive advantage to these organisms within gut 
environment, BSH enzymes have also been linked to reduced serum 
cholesterol levels in the host organism (Begley, Hill, & Gahan, 2006). 
The ability of the surviving strains to colonise the gut, either transiently 
or on a more long-term basis, is also considered a useful quality as it 
allows longer exposure of the host to any beneficial effects that these 
strains may express. The ability of strains to adhere to the intestinal 
lining once ingested is, therefore, a highly sought-after quality, with 
either whole cell lines or intestinal mucus used as the binding surface 
(Servin & Coconnier, 2003). Additionally, the ability of strains to inhibit 
the binding of food-borne pathogens can also be tested for in vitro, with 
Escherichia coli, Listeria monocytogenes and Salmonella being typical 
antagonistic targets (Balamurugan, Chandragunasekaran, Chellappan, 
Rajaram, Ramamoorthi, & Ramakrishna, 2014; Yu, Wang, & Yang, 
2011). In addition, some bacteria, including specific strains of NSLAB 
are also capable of producing exopolysaccharides (EPS), high molecular- 
weight polymers produced from sugars, which can affect their host by 
modulating immune responses (Ryan, Ross, Fitzgerald, Caplice, & 
Stanton, 2015). 
To the best of our knowledge, all studies to date that have sought to 
elucidate the potential of NSLAB isolates to survive gastric transit and 
display established probiotics traits have started with individual isolates 
selected from cheese following conventional plating techniques which 
do not include any step to select for the capacity to survive gastric 
exposure. These techniques start by separating the bacteria from the 
cheese matrix by blending with a buffer followed by serial dilution and 
plating. As the aim of this study was to evaluate the ability of NSLAB of 
the Lactobacillus genus isolated from Cheddar cheeses to survive gastric 
passage and to determine if strains capable of doing so expressed traits 
beneficial to the host, the first step in our selection involved exposure of 
NSLAB populations separated from the cheese matrix to simulated 
stomach duodenum passage (SSDP) that includes exposure to high acidic 
conditions and bile acids, prior to selective plating. Strains surviving this 
selection procedure were then investigated via subtractive screening for 
their probiotic potential using the in vitro tests listed in the Food and 
Agriculture Organisation (FAO) guidelines (2002) for screening of po-
tential probiotics (Food and Agriculture Organization Of The United 
Nations, 2006). 
2. Materials and methods 
2.1. Bacterial strain source and storage 
Twelve Irish Cheddar Cheeses were selected for this study produced 
from both raw and pasteurised bovine milk. Nine of these were com-
mercial brands and three were sampled from Cheddar produced at pilot 
scale (Moorepark Technology Limited, Teagasc Moorepark) for a sepa-
rate study. All NSLAB isolated from these cheeses were stored in MRS 
broth (BD DifcoTM) with 25% Glycerol (Sigma Aldrich). Long-term 
stocks were stored at − 80 ◦C. Working stocks were kept at − 20 ◦C, 
and were propagated twice in MRS broth, then twice on MRS plates for 
activation and to ensure purity prior to testing. All MRS broth/agar was 
prepared with 0.05% (w/v) L-Cysteine-HCl. 
Enteropathogenic E. coli (EPEC) 0111:H2 (strain NCTC 8007) was 
obtained from the National Collection of Type Cultures (NCTC; London, 
UK) and was stored at − 20 ◦C in BHI broth with 50% glycerol (v/v). 
Prior to the Pathogen Exclusion Assays (2.10 below), E. coli was grown 
overnight in BHI broth at 37 ◦C, aerobically. 
2.2. Screening for NSLAB that survive simulated stomach duodenum 
passage 
The ability of NSLAB to survive passage through the upper gastro-
intestinal tract was tested in vitro via Simulated Stomach Duodenum 
Passage (SSDP), as reported by Pisano et al. (2014). This protocol ex-
poses the NSLAB to the acidic conditions of the stomach (pH 3.0) fol-
lowed contact with bile acids as would be experienced duodenum, the 
two primary tests identified by the FAO for the selection of strains with 
probiotic potential. 5–10 g of each cheese (obtained with a sterile cheese 
trier) was diluted 1:10 in sterile 2% (w/v) trisodium citrate (VWR™ 
27833.260), followed by 5 min of maceration with a stomacher (Bag-
Mixer® 400P, Interscience). 10 mL of the resultant slurry was centri-
fuged at 4000 rpm for 5 min, followed by aspiration of the supernatant. 
The pellet was resuspended in 10 mL of simulated gastric juice (6.2 g/L 
NaCl, 2.2 g/L KCl, 0.22 g/L CaCl2, 1.2 g/L NaHCO3, 0.3% pepsin, at pH 
3.0) and incubated for 90 min at 37 ◦C, with shaking for peristalsis 
simulation. 17.5 mL of synthetic duodenum juice (6.4 g/L NaHCO3, 
0.239 g/L KCl, 1.28 g/L NaCl, and 0.1% pancreatin, at pH 7.4) and 4 mL 
of 10% (w/v) Ox gall powder (Sigma) containing bile acids were then 
added to the cell suspension, simulating passage into the upper intestinal 
tract, and incubation was continued for a further 90 min at 37 ◦C, with 
shaking. The suspension was then centrifuged, the supernatant dis-
carded, and the pellet was resuspended in maximum recovery diluent 
(MRD) (Oxoid CM0733). Survival rates of the bacteria following SSDP 
were determined via plating serial dilutions in MRD of the samples in 
duplicate prior to (Time 0, before addition of simulated gastric juice) 
and following (Time 180, following the full 180 min of exposure to both 
simulated gastric and duodenum juice) exposure to SSDP conditions. 
Samples were plated on MRS, in duplicate, and incubated for 48 h at 
37 ◦C, anaerobically. Screening on each cheese was performed in 
triplicate. 
2.3. Pulsed field gel electrophoresis 
Following SSDP, 20 colonies from countable MRS plates for each 
cheese were randomly selected, purified and DNA fingerprint profiles 
were generated using Pulsed Field Gel Electrophoresis (PFGE) as 
described by Stefanovic et al (Stefanovic, Kilcawley, Rea, Fitzgerald, & 
McAuliffe, 2017), with modifications. Bacterial cultures were inoculated 
at 1% and grown overnight in 10 mL MRS broth containing 0.02 M 
threonine, anaerobically. 0.5 mL of each overnight culture was centri-
fuged at 12000 rpm for 5 min, the supernatant aspirated and the pellet 
resuspended in 0.5 mL of Buffer 1 (0.01 M Tris-HCl, 1 M NaCl, pH 7.6). 
The cell suspension was re-centrifuged, the supernatant aspirated and 
the pellet resuspended in 0.3 mL Buffer 1, which was then mixed with an 
equal volume of 2% low melting point agarose in 0.125 M EDTA (pH 
7.6) and pipetted into PFGE plug moulds and allowed to solidify at room 
temperature. Plugs were left overnight (16–24 h), rocking, at 37 ◦C in 
1 mL of previously prepared EC Buffer (0.1 M EDTA, 1. 0 M NaCl, 1% 
[w/v] N-Lauroylsarcosine sodium salt, 0.006 M Tris-HCl, pH 7.6) with 
10 mg/mL Lysozyme and 20 Units/mL Mutanolysin. Subsequently, the 
EC buffer was aspirated and replaced with 1 mL of Buffer 2 (0.5 M EDTA, 
1% (w/v) N-Lauroylsarcosine sodium salt, pH 8.0) with 0.5 mg/mL 
Proteinase K, and left overnight (stationary) at 55 ◦C. Plugs were washed 
twice in TE 10/1 Buffer (0.001 M EDTA, 0.01 Tris-HCl, pH 8.0) with 
0.001 M phenylmethylsulphonyl fluoride (PMSF) for 1 h each at 37 ◦C 
(stationary) and were then stored in Eppendorf tubes containing 1 mL TE 
10/100 Buffer (0.1 M EDTA, 0.01 Tris-HCl, pH 8.0) at 4 ◦C until 
required. Plugs were then cut into 1–2 mm slices and washed thrice in 
1 mL TE 10/0.1 (0.0001 M EDTA, 0.01 Tris-HCl, pH 8.0) at room 
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temperature for 30 min each with gentle rocking. Slices were subse-
quently transferred to Eppendorf tubes containing 0.1 mL 1X Buffer 
Tango (Thermo Scientific) for minimum 30 min at 4 ◦C, followed by the 
addition of 0.4 µL of AscI restriction enzyme (Thermo Scientific) and 
incubation continued for 24 h at 37 ◦C (stationary). 0.5 mL of 0.5 M 
EDTA was added to the slices to deactivate the enzyme, followed by 
loading of the slices into wells of a 200 mL 1% agarose Pulsed Field 
Certified™ (Bio-Rad) gel prepared with 0.5X dilution Tris-borate EDTA 
(TBE) buffer (55 g/L Boric Acid), 40 mL/L 0.5 M EDTA [pH 8.0], 108 g/L 
Tris). Gels were run using a CHEF-DR® II PFGE apparatus (Bio-Rad) in 
2.3 L of the same 0.5X TBE Buffer using the following parameters: Initial 
Switch Time 1 Second, Final Switch Time 20 Seconds, 6 V/cm, for 16 h, 
at 14 ◦C. Resulting gels were stained with 10 mg/mL ethidium bromide 
(E1510 Merck) for 1 h, followed by 2 destaining washes in distilled 
water for 40 min each. Gels were photographed using an Alpha Imager® 
3400 (Alpha Innotech Corp). Lambda PFG Ladder (New England Bio-
Labs® Inc.) was loaded with every gel as a reference marker. 
2.4. PFGE fingerprint profile analysis and dendrogram assembly 
BioNumerics® 7.5 Software (Applied Maths) was used to analyse the 
PFGE images, as per the method described by Stefanovic et al. (2017). 
Dendrograms were assembled using the Unweighted Pair Group Method 
Using Average Linkage (UPGMA) distance matrix method and curve- 
based Pearson correlation. Profiles that had ≥ 95% similarity were 
grouped as the same strain (Shutt, Pounder, Page, Schaecher, & Woods, 
2005). 
2.5. 16S rRNA gene sequencing 
Cultures were sent to GENEWIZ (Hope End, Takeley, Essex, CM22 
6TA, United Kingdom) for DNA extraction, amplification and 16S rRNA 
gene sequencing. Isolated colonies previously grown on MRS agar for 
48 h at 37 ◦C were transferred to cryotubes (Thermo Scientific) con-
taining 1 mL MRS agar via an inoculation needle. Following 24 h growth 
at 37 ◦C, the cultures in the cryotubes were sent to GENEWIZ. Universal 
16S rRNA primers 5′-AGAGTTTGATCCTGGCTCAG-3′ (forward) and 5′- 
ACGGCTACCTTGTTACGACTT-3′ (reverse) were used to generate PCR 
products of approximately 1.4 KB, the DNA sequence of which were then 
obtained and sequenced following GENEWIZ DNA sequencing in-
structions. FASTA sequencing data was analysed using Lasergene 8 
software (DNAStar Inc., Madison, WI), specifically the SeqMan and 
EditSeq tools, and resulting sequences were compared with pre-existing 
genomic data using the nucleotide basic local alignment search tool 
(BLASTn Suite) on the National Centre for Biotechnology Information 
(NCBI) server. 
2.6. Bile salt hydrolase activity 
A modified version of the method described by Pisano et al. (2014) 
was used for this analysis. NSLAB strains were grown overnight in each 
of (i) MRS broth, (ii) 0.3% (w/v) bile modified (m) MRS broth and (iii) 
0.5% (w/v) mMRS broth. Modified MRS containing two levels of 
physiologically relevant bile concentrations were used in parallel with 
regular MRS to determine whether BSH activity could be induced (Ruiz, 
Margolles, & Sánchez, 2013). Following overnight incubation, BSH ac-
tivity was screened for by loading 0.025 mL of each of the three variants 
of overnight NSLAB culture into wells (5 mm in diameter) bored in 
mMRS agar plates containing 0.03% (w/v) bile (Difco™ Oxgall, BD), 
0.375 g/L CaCl2 and 1% agar, in duplicate. The resulting bile plates were 
incubated for 72 h at 37 ◦C, anaerobically. The presence of opaque 
haloes of deconjugated bile surrounding wells identified strains 
expressing BSH enzyme. Lactobacillus reuteri NCBI 30242 cultures were 
used in parallel as a positive control due to their documented ability to 
produce BSH enzymes. 
2.7. Antibiotic resistance profile 
VetMIC™ plates (National Veterinary Institute of Sweden, Uppsala, 
Sweden) were used to determine the resistance/susceptibility of BSH- 
producing strains to antibiotics of importance as listed by the Euro-
pean Food Safety Authority in 2012: Ampicillin, Vancomycin, Genta-
micin, Kanamycin, Streptomycin, Erythromycin, Clindamycin, 
Tetracycline and Chloramphenicol (Guidance on the assessment of 
bacterial susceptibility to antimicrobials of human and veterinary 
importance, 2012). Fresh Lactobacillus cultures were streaked on MRS 
plates and incubated for 48 h at 37 ◦C, anaerobically. Colonies were then 
suspended in MRD, and a portion of this was transferred to 10 mL ISO- 
MRS broth (90% Iso-Sensitest broth [Thermo Scientific], 10% MRS 
broth) to achieve a final inoculum of ≈5x105 cfu/mL. Wells of both 
VetMIC™ Lact-1 and Lact-2 plates were seeded with 0.1 mL from the 
ISO-MRS cultures, sealed with clear film (as provided with the VetMIC™ 
plates) and incubated anaerobically at 37 ◦C for 48 h. Growth of 
Lactobacillus cultures in the form of pellets at the bottom of the wells was 
examined using a backlight (colony counter) and the minimum inhibi-
tory concentration (MIC) was recorded as the lowest concentration able 
to completely inhibit visible growth. Experiments were repeated 3 times. 
2.8. Cell culture and establishment of co-culture 
Caco-2 and mucus-producing HT29-MTX cells were grown in tandem 
and a co-culture was established as an intestinal model using the method 
reported by Yi et al., with modifications (Li, Arranz, Guri, & Corredig, 
2017). Caco-2 and HT29-MTX cultures were obtained from Istituto 
Zooprofilattico Sperimentale di Brescia (Italy) and Public Health En-
gland General Cell Collection (ECACC 12040401), respectively. Both 
cells lines were resuscitated from Liquid N2 and maintained separately 
in Dulbecco’s Modified Eagle’s Medium (DMEM) medium (Merck 
D5796) supplemented with 10% Foetal Bovine Serum (FBS) (Merck 
F7524), 1% non-essential amino acids (NEAA) (M7145), 1% antibiotic 
solution (100 U/mL penicillin, 100 mg/mL streptomycin) (Merck 
P0781) and 2 mM L-glutamine (Merck 59202C) and were incubated at 
37 ◦C in 5% CO2 in a humidified atmosphere. Cells were sub-cultured 
into 75-cm2 tissue culture flasks (Merck C7231) every 2–3 days, once 
a confluence of ≥ 80% was reached. For co-cultures, Caco-2 and HT29- 
MTX were inoculated at a ratio of 3:1 onto the apical membrane of the 
Corning® Transwell® Polyester Membrane Cell Culture Inserts (Merck 
CLS3460) with a total of 6x104 cells per well. Co-cultures were allowed 
to reach confluence, differentiate and (in the case of the HT29-MTX 
cells) produce mucus for 21 days. Media was changed for both apical 
and basolateral layers every 2–3 days, and transepithelial electrical 
resistance (TEER) measurements were taken prior to media changes to 
monitor the integrity of the developing monolayer. One day prior to 
Bacterial Adhesion Assays and Pathogen Exclusion Assays, media in the 
Transwells was replaced with antibiotic-free, complete DMEM. 
2.9. Adhesion assays 
Mucus adhesion assays were carried out as per Morrin et al, Morrin, 
Lane, Marotta, Bode, Carrington, Irwin, & Hickey (2019) with modifi-
cations. Caco-2 cells were used between passages 41–53, while HT29- 
MTX cells were used between passages 66–79. Lactobacillus cultures 
were grown overnight in MRS broth and the O.D. 600 measurement was 
taken via a spectrophotometer. This reading was used to determine the 
necessary volume required for an O.D. 600 reading of 0.4 in 10 mL, 
followed by centrifugation of the appropriate volume per strain at 
5000 rpm for 5 min. Cultures were resuspended in 10 mL un- 
supplemented DMEM and incubated anaerobically at 37 ◦C for 2 h, to 
reach a final O.D. of 0.5 (≈ 1x108 CFU/ml). Quantification of the exact 
CFU/mL per bacterial suspension was enumerated via serial dilutions 
and spread-plating onto MRS, followed by anaerobic incubation for 48 h 
at 37 ◦C. Media from apical and basolateral layers of Caco-2/HT29-MTX 
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co-culture wells were aspirated and two phosphate buffered saline (PBS) 
(Merck D8537) washes were performed, followed by complete aspira-
tion of the used PBS in both cases. Subsequently, 0.5 mL (≈ 5 × 107 
CFU/ml) of each bacterial culture was added to separate co-culture wells 
(in triplicate) and were incubated for 2 h at 37 ◦C, anaerobically. Post 
incubation, wells were washed thrice with PBS for removal of loosely or 
non-adherent bacteria and 0.5 mL 0.1% Triton X100 (Merck T8787) was 
added to each well and left at room temperature for 15 min to allow for 
lysis of the eukaryotic cells. Serial dilutions of the lysates were prepared 
and plated via spread-plating on MRS. Following anaerobic incubation 
for 48 h at 37 ◦C, CFU/mL were enumerated and % adherence of each 
bacterial culture was determined using CFU/mL of the original sus-
pensions calculated previously ([CFU/mL of adherent bacteria ÷ CFU/ 
mL of total initial bacteria] × 100). Adhesion assays were performed in 
triplicate. Lb. rhamnosus GG (ATCC 53103) cultures were used in parallel 
as a positive control. 
2.10. Pathogen exclusion assays 
The ability of two NSLAB strains to inhibit binding of an enteric 
pathogen to cocultured cells was examined using an exclusion model. 
Pathogen Exclusion Assays were carried using the Adhesion Assay 
method (2.9 above), with minor modifications. Caco-2 cells were used 
between passages 39–43, while HT29-MTX cells were used between 
passages 61–66. Overnight E. coli cultures in BHI broth were adjusted to 
an O.D. 600 of 0.01 (≈8x106 CFU/mL), centrifuged at 10,000 rpm for 
5 min and resuspended in DMEM. Quantification of the exact CFU/mL 
per bacterial suspension was enumerated by serial dilutions and spread- 
plating onto Eosin Methylene Blue (EMB) Agar (Oxoid 0069), followed 
by aerobic incubation for 24 h at 37 ◦C. NSLAB strains were incubated 
anaerobically at 37 ◦C with the co-cultures for 1 h before being washed 
twice with PBS (for removal of free or loosely bound Lactobacillus) fol-
lowed by the addition of 0.5 mL (≈4x106 CFU/mL) of the E. coli sus-
pension and another hour of incubation under the same conditions. The 
cells were lysed using the same procedure as before, with serial dilutions 
being plated on EMB agar for E. coli enumeration. Controls included 
wells with exclusively Lactobacillus or E. coli cultures that were incu-
bated for 2 h. Percentage exclusion of E. coli was calculated by 
comparing the CFU/mL of E. coli that adhered to the co-culture when 
exclusively present in the wells versus when present in conjunction with 
the NSLAB strain (100 – {[CFU/mL of adherent E. coli in the presence of 
NSLAB ÷ CFU/mL of adherent E. coli exclusively] × 100}). Pathogen 
Exclusion Assays were performed in triplicate. 
2.11. Exopolysaccharide production 
Ruthenium red milk agar was used to determine whether Lactoba-
cillus strains were capable of producing EPS, as per the method by Ste-
fanovic and McAuliffe (2018). Freshly grown cultures were streaked on 
ruthenium red milk agar plates (10% reconstituted skim milk, 0.5% 
yeast extract, 0.08% ruthenium red [Sigma R2751], 1.5% agar), in 
triplicate, and incubated for 48 h at 37 ◦C, under anaerobic conditions. 
White colonies indicated an EPS-producing strain, while colonies that 
remained pink indicated a negative result. The Lactobacillus paracasei 
DPC1116 strain, an established EPS-producer, was used in parallel as a 
positive control. EPS production experiments were performed in 
triplicate. 
2.12. Whole genome sequencing and annotation 
Genomic DNA from Lb. rhamnosus DPC7102 and Lb. paracasei /casei 
DPC 7150 was isolated from overnight cultures grown in MRS broth at 
37 ◦C using the DNeasy UltraClean Microbial Kit (Qiagen), as per the 
included protocol, and the quantity was measured using the NanoDrop 
3300 fluorospectrometer (Thermo Fisher Scientific). Contig construc-
tion was provided by Microbes NG (http://www.microbesng.uk). 
Genomic DNA libraries were prepared using Nextera XT Library Prep Kit 
(Illumina, San Diego, USA) following the manufacturer’s protocol, with 
two modifications: 2 ng of DNA were used as input and PCR elongation 
time was set to 1 min. Quantification and library preparation of DNA 
was carried out on a Hamilton Microlab STAR automated liquid 
handling system. Kapa Biosystems Library Quantification Kit for Illu-
mina was used for quantification of pooled libraries on a Roche light 
cycler 96 qPCR machine. The Illumina HiSeq was used to sequence 
genomic libraries using a 250 bp paired end protocol. Reads were 
adapter trimmed using Trimmomatic 0.30 with a sliding window quality 
cutoff of Q15 (Bolger, Lohse, & Usadel, 2014). De novo assembly was 
performed on samples using SPAdes version 3.7 (Bankevich et al., 2012). 
Contigs were annotated with the NCBI Prokaryotic Genome Annotation 
Pipeline (PGAP) (Haft et al., 2018). Average Nucleotide Identity (ANI) 
and OrthoANI values for both strains were calculated using the online 
tools from Kostas Lab and EZ BioCloud, respectively (Rodriguez-R & 
Konstantinidis, 2016; Yoon, MinHa, Lim, Kwon, & Chun, 2017). Res-
Finder 3.2, VirulenceFinder 2.0, and PathogenFinder 1.1 databases were 
used for in silico analysis of potential virulence and acquired antimi-
crobial resistance genes (Cosentino, Voldby Larsen, Møller Aarestrup, & 
Lund, 2013; Joensen, Scheutz, Lund, Hasman, Kaas, & Aarestrup, 2014; 
Zankari et al., 2012). Where necessary, Lb. rhamnosus GG 
(NC_013198.1) and Lb. paracasei ATCC 334 (NC_008526.1) were used as 
reference strains for Lb. rhamnosus 7102 and Lb. paracasei 7150, 
respectively. 
2.13. Statistical analysis 
Statistical analysis and graphs were generated using the IBM SPSS® 
software platform for Windows (Ver. 26). Adhesion results are expressed 
as a mean ± SD of the results of three independent assays conducted in 
triplicate. Tukey’s Honest Significant Difference test was used to 
determine statistically significant differences between the control and 
test strains, where p ≤ 0.05 was considered significant. 
3. Results 
3.1. Selection and identification of NSLAB demonstrating ability to 
survive SSDP 
Screening of NSLAB from 12 Irish Cheddar cheeses was carried out 
based on the ability of the bacteria to survive SSDP which includes 
exposure to gastric pH levels and bile acids, the two primary tests 
identified by the FAO for the selection of strains with probiotic potential. 
NSLAB populations ranged from 2.26 × 105 to 1.04 × 108 CFU/g prior to 
SSDP. Exposure to SSDP resulted in population reductions in all cases 
with log reduction ranging from 0.03 to 2.84 being observed (Table 1). 
In an effort to select a representative population of acid resistant, bile 
Table 1 
NSLAB population numbers in Cheddar cheese pre- and post- SSDP.   
NSLAB CFU/g 
Cheese Milk Average CFU/g Log Reduction 
Pre SSDP Post SSDP 
1 Raw 6.56E + 06 6.13E + 06 0.03 
2 Raw 1.45E + 07 8.66E + 06 0.22 
3 Pasteurized 9.10E + 06 5.22E + 06 0.24 
4 Pasteurized 2.26E + 05 1.26E + 05 0.25 
5 Pasteurized 1.40E + 08 1.19E + 07 1.08 
6 Pasteurized 6.30E + 07 5.83E + 07 0.03 
7 Pasteurized 6.61E + 07 1.60E + 05 2.62 
8 Pasteurized 2.84E + 07 1.75E + 05 2.21 
9 Pasteurized 4.23E + 07 7.30E + 04 2.74 
10 Pasteurized 5.91E + 07 2.53E + 06 1.37 
11 Pasteurized 1.08E + 07 1.55E + 04 2.84 
12 Pasteurized 6.18E + 06 2.44E + 06 0.40  
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acid tolerant NSLAB twenty colonies were randomly selected and puri-
fied from the post SSDP MRS plates for each cheese resulting in 240 
isolates. These were then subjected to a subtractive screening method-
ology (Pisano et al., 2014) the first step of which was the generation of 
PFGE profiles for each isolate in an effort to elucidate how many unique 
strains were present in each cheese. Dendrograms were generated, one 
for each cheese, and any isolates with a ≥ 95% similarity in the same 
cheese were grouped as a single strain and only one isolate from each 
cluster was picked for subsequent analysis. Using this approach, 76 
unique strains were identified (Table S1). The number of individual 
strains identified in each Cheddar cheese varied considerably, with the 
Bionumerics software identifying up to 12 different bacterial strains in 
some cheeses. Conversely, Cheddar cheeses 5, 10 and 12 were found to 
only contain one strain each capable of surviving SSDP. A representative 
isolate from each strain cluster was selected for further study and each 
was assigned a unique Teagasc DPC culture collection number 
(7081–7156, inclusively). 16S rRNA gene sequence analysis identified 
the strains as constituting Lb. paracasei/casei (38 strains), Lb. curvatus 
(13 strains), Lb. plantarum (12 strains), Lb. helveticus (6 strains), Lb. 
rhamnosus (4 strains), Lb. coryniformis (2 strains) and Streptococcus 
thermophilus (1 strain). While a common NSLAB species was not isolated 
from all cheeses, Lb. casei/paracasei isolates were isolated from ten of the 
twelve cheeses. Lb. plantarum was the second most common species of 
NSLAB capable of surviving SSDP, with isolates being found in three of 
the twelve cheeses. Lb. curvatus and Lb. helveticus strains were found in 
two cheeses, while all the Lb. coryniformis and Lb. rhamnosus strains 
originated from cheese 8 and cheese 6, respectively (Table S1). 
3.2. Bile salt hydrolase screening 
BSH activity was detected in 30 of the 76 strains, although not all 
tested positive for activity under all three culture conditions (Table 2). 
All 30 BSH-positive strains produced BSH when incubated overnight in 
normal MRS, although the diameters of the haloes surrounding the wells 
differed. None of the Lb. curvatus or Lb. helveticus strains produced 
deconjugated bile salt haloes, and neither did the one S. thermophilus 
strain tested. In contrast, only 1 of the 12 Lb. plantarum strains was 
incapable of BSH production. All 11 of the BSH positive Lb. plantarum 
strains were capable of producing deconjugated bile haloes with di-
ameters of ≥ 2.0 cm when previously incubated in normal MRS and the 
majority reproduced haloes of equal size or greater when previously 
inoculated in MRS broth containing bile (with the exceptions being 7094 
and 7095). Of the 38 Lb. casei/paracasei strains tested, only 17 exhibited 
BSH activity. All BSH positive Lb. casei/paracasei strains were capable of 
producing haloes when previously incubated in standard MRS, but this 
activity was not always retained when previously grown in broth con-
taining bile. A single strain each of Lb. rhamnosus (out of a possible 4 
strains) and Lb. coryniformis (1 of 2 strains) also produced BSH activity, 
both of which showed consistent BSH activity regardless of which cul-
ture conditions were used. 
3.3. Antibiotic resistance profiles 
The 30 strains displaying BSH activity were tested for antibiotic 
sensitivity. Ten were found to be resistant to antibiotics at levels higher 
than those specified by the EFSA in 2012 (Table 3). All tested strains 
exhibited resistance to vancomycin (which is common among lactoba-
cilli) at the highest concentration (128 µg/mL) provided in the assay; 
however, susceptibility levels to this antibiotic are not required by the 
EFSA and were, therefore, recorded as such (Table 3). The MICs of the 
other 20 Lactobacillus strains were always equal to or lower than the 
acceptable cut-off values and thus, these were taken forward to the next 
stage of the subtractive screening protocol. The most prominent resis-
tance phenotype expressed in the resistant lactobacilli was the ability to 
grow in the presence of high concentrations of chloramphenicol, with 8 
of the 10 isolates having MIC values greater than the EFSA cut-off 
values. Tetracycline resistance was observed in 5 resistant strains, 
while kanamycin resistance was observed in 3 strains (all of which 
belonged to the Lb. casei/paracasei species). In 6 cases, resistance to 
chloramphenicol and 1 other antibiotic was observed. 
3.4. Lactobacillus adherence to a Mucus-Producing cell model 
Seven of the twenty Lactobacillus strains that were sensitive to anti-
biotics were selected, and their ability to adhere to a mucus-producing 
Caco-2/HT29-MTX co-culture was assessed. The criteria used to select 
strains for screening were that at least one strain per species was selected 
and the number of strains chosen per species was based on their overall 
abundance during the original isolation. Lb. rhamnosus GG was used as a 
positive control due to its established role as a probiotic with excellent 
adherence to epithelial models (Segers & Lebeer, 2014). Following three 
independent replicates, Lb. casei/paracasei DPC7110, Lb. casei/paracasei 
DPC7149, Lb. plantarum DPC7126 and Lb. plantarum DPC7096 were 
found to have adherence values that were statistically significantly 
different (p < 0.05) from and less than the positive control (Fig. 1). The 
remaining Lb. casei/paracasei (7150, 7087) and Lb. rhamnosus (7102) 
strains’ demonstrated adherence values that were not statistically 
significantly different from the positive control. While the control strain 
exhibited the highest adherence value (90.6 ± 8.2%), Lb. rhamnosus 
strain DPC7102 showed the highest adherence of the strains of interest, 
at 79.2 ± 8.1%. The other 2 Lb. casei/paracasei strains of interest that 
performed well were strain 7150 and strain 7087, which had adherence 
values of 64.0 ± 9.1% and 58.0 ± 11.5%, respectively. Adherence to the 
Table 2 
BSH activity of selected NSLAB strains in absence of or post exposure to physi-
ological levels of bile. + Deconjugated bile halo with diameter of <1.0 cm, ++
Deconjugated bile halo with diameter of ≥ 1.0 cm, +++ Deconjugated bile halo 
with diameter of 1.0–2.0 cm, ++++ Deconjugated bile halo with diameter of 
2.0–3.0 cm, * Lb. reuteri NCIMB 30242.   
Bile Salt Hydrolase Activity 
Species Strain Incubation Conditions 
MRS MRS + 0.3% Bile MRS + 0.5% Bile 
Lb. casei/paracasei 7086 +++ +++ +++
7087 ++ + -  
7091 ++ – –  
7100 ++ ++ ++
7104 ++ + ++
7110 ++ ++ ++
7111 ++ ++ ++
7143 ++ + ++
7145 + + ++
7149 ++ ++ +
7150 ++ – –  
7151 ++ – –  
7152 + – ++
7153 ++ ++ –  
7154 ++ – –  
7155 ++ – –  
7156 ++ – –  
Lb. plantarum 7081 +++ ++++ +++
7083 ++++ ++++ +++
7094 +++ ++ ++
7095 +++ +++ ++
7096 +++ +++ +++
7097 +++ +++ +++
7126 ++++ +++ +++
7132 ++++ +++ +++
7133 +++ +++ +++
7134 ++++ +++ +++
7141 +++ ++++ ++++
Lb. rhamnosus 7102 ++ ++ ++
Lb. coryniformis 7127 ++++ +++ +++
Positive Control* 30242 ++++ ++++ ++++
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mucus-producing mammalian co-culture varied greatly among strains, 
often accompanied with high standard deviations. 
3.5. Ability of Lactobacillus strains to inhibit Enteropathogenic E. Coli 
binding to Mucus-Producing cells 
In order to assess further probiotic potential, the two Lactobacillus 
strains with the highest rates of adherence in vitro, representing two 
species of Lactobacillus namely Lb. rhamnosus DPC7102 and Lb. casei/ 
paracasei DPC7150, were tested for their ability to inhibit the binding of 
a known enteropathogenic E. coli (EPEC) strain to mucus (Fig. 2). The 
experiment performed used an inhibition model whereby the lactoba-
cilli were added to the Caco-2/HT29-MTX co-culture an hour prior to the 
addition of the pathogen, thereby examining the lactobacilli’s ability to 
‘exclude’ binding of the pathogen to the mucins and mammalian cells. 
Lb. rhamnosus DPC7102 was able to exclude 44.2 ± 9.6% of the total 
E. coli from adhering to the mucus co-culture, while Lb. casei/paracasei 
DPC7150 excluded 25.7 ± 2.1% of total E. coli. 
3.6. Exopolysaccharide production by selected Lactobacillus strains 
The ability of lactic acid bacteria (LAB) to produce EPS is seen as a 
benefit, from both a commercial and health point of view. Therefore, 
DPC7102 and DPC7150 were grown on skim milk plates containing 
ruthenium red agar, in parallel with a known EPS-producing positive 
control (DPC1116). Both strains of interest and positive control strain 
produced white colonies on the pink plates (Fig. 3), demonstrating that 
they each produce EPS when grown on skim milk. 
3.7. Genome characteristics of Lb. Rhamnosus DPC7102 and Lb. 
Paracasei DPC 7150 
Whole genome sequencing and annotation was undertaken on the 
two strains Lb. rhamnosus DPC7102 and Lb. paracasei/casei DPC 7150 in 
an effort to fully characterise the strains to species level and to deter-
mine if either contained antibiotic resistance, virulence or other genes 
associated with human pathogens. The data obtained (Table 4) 
demonstrated that both ANI and OrthoANI values were > 95%, 
Table 3 
Antibiotic sensitivity profiles of selected NSLAB strains. * Va, Vancomycin; Am, Ampicillin; Gm, Gentamicin; Km, Kanamycin; Sm, Streptomycin; Em, Erythromycin; 
Cl, Clindamycin; Tc, Tetracycline; Cm, Chloramphenicol. 1 not required as per EFSA Guidelines. MIC (µg/mL) values in bold indicate presence of antibiotic resistance 
as per the EFSA Guidelines.   
Minimum Inhibitory Concentration (MIC) Values of Resistant Lactobacilli to Antibiotics of Interest 
Species Strain Antibiotic* (MIC as µg/mL) 
Va Am Gm Km Sm Em Cl Tc Cm 
Lb. casei/paracasei 7086 n.r.1 <2 <2 <64 <16 <0.25 <0.25 <32 <16  
7100 n.r. <2 <2 <64 <16 <0.25 <0.25 <4 <16  
7104 n.r. <1 <8 <128 <64 <0.06 <0.12 <2 <4  
7143 n.r. <2 <4 <128 <16 <0.06 <0.12 <1 <8  
7145 n.r. <2 <4 <128 <16 <0.06 <0.25 <1 <8  
7152 n.r. <1 <4 <64 <8 <0.06 <0.12 <2 <8  
Lb. plantarum 7081 n.r. <2 <2 <64 n.r. <0.25 <0.5 >64 <16  
7083 n.r. <1 <2 <64 n.r. <0.25 <0.5 >64 <16  
7141 n.r. <1 <2 <32 n.r. <0.25 <0.5 >64 <8  
Lb. coryniformis 7127 n.r. <0.5 <1 <16 <8 <0.12 <0.5 <32 <8  
Fig. 1. Ability of Lactobacillus strains to adhere to 
Caco-2/HT29-MTX co-culture. Lactobacillus rham-
nosus GG was used as a control. Results are 
expressed as the mean percentage of 3 independent 
experiments performed in triplicate, with error bars 
representing standard deviation. * Statistically sig-
nificant differences occurred compared to the con-
trol (GG Control) strain (p < 0.05). ** Highly 
statistically significant differences occurred 
compared to the control (GG Control) strain 
(p < 0.001).   
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indicating that they are the same species as the reference strains used 
confirming that DPC715 is in fact a Lb. paracasei (Rodriguez-R & Kon-
stantinidis, 2016). ResFinder 3.2 detected no acquired antibiotic resis-
tance genes in either draft genome. The gene RRS (a 16 S ribosomal RNA 
gene) from Mycobacterium tuberculosis was the only exception in Lb. 
rhamnosus 7102, but the coverage was only ≈4% (with 60% being the 
minimum coverage threshold cutoff) (data not shown). VirulenceFinder 
2.0 detected no genes associated with virulence in either genome (data 
not shown). PathogenFinder 1.1 predicted that neither organism is a 
likely human pathogen. 
Fig. 2. Ability of Lactobacillus strains to inhibit the binding of Enteropathogenic E. coli 0111:H2 to Caco-2/HT29-MTX co-culture. Results are expressed as the mean 
percentage of 3 independent experiments performed in triplicate, with error bars representing standard deviation. 
Fig. 3. Growth of white colonies on ruthenium red skim milk agar indicating EPS production. (A) Positive control Lb. paracasei DPC1116; (B) and (C) test strains Lb. 
rhamnosus DPC7102 and Lb. paracasei DPC 7150 respectively. 
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4. Discussion 
Initially, samples of 12 Irish Cheddar cheeses were subjected to SSDP 
followed by plating for viable NSLAB on MRS agar. Survivors under 
SSDP conditions, which include exposure to gastric pH conditions fol-
lowed by bile acids the two primary criteria identified by the FAO for the 
selection of strains with probiotic potential (Food and Agriculture Or-
ganization Of The United Nations, 2006) provided an indication of po-
tential of NSLAB to transit through the upper intestinal tract and thus, 
their potential to colonise the host intestines. Apart from Cheddar cheese 
4, the NSLAB populations were in excess of 106 CFU/g prior to SSDP, 
which is the accepted minimum level at which probiotics should be 
present in food, from which a portion can be consumed daily to 
administer the recommended 108-109 CFU (Kechagia et al., 2013). 
Following exposure to SSDP, log reductions of between 0.03 and 2.84 
were observed in the NSLAB populations, with > 106 CFU/g being 
observed in 7 of the 12 cheeses tested. These data provide direct evi-
dence for the first time to support the hypothesis that Cheddar cheese 
contains NSLAB populations of which a large proportion are capable of 
surviving simulated gastric digestion and thus will arrive in the small 
intestine in a viable state. The NSLAB in this study were extracted from 
the cheese prior to exposure to SSDP; however, it is expected that under 
normal conditions of cheese consumption the presence of the cheese 
matrix would provide additional protection, thus, enhancing NSLAB 
survival and transit to the gut (Gardiner, Stanton, Lynch, Collins, Fitz-
gerald, & Ross, 1999). Cheddar cheese may, therefore, serve as an effi-
cient food vehicle for delivery of acceptable numbers of viable NSLAB to 
the gut where they may exert health benefits. The data presented here 
indicate that cheese contains beneficial bacteria at high levels, which 
can then potentially colonise the human intestines and exert further 
beneficial effects (Settanni & Moschetti, 2010). This is in agreement 
with the work of other groups who have also confirmed the feasibility of 
cheese as a competent microbe/probiotic delivery matrix (Gardiner 
et al., 1999; Gomes da Cruz, Alonso Buriti, Batista de Souza, Fonseca 
Faria, & Isay Saad, 2009; Karimi, Mortazavian, & Da Cruz, 2011; Sharp, 
McMahon, & Broadbent, 2008; Zhang et al., 2013). 
Initially, 76 isolates that were resistant to simulated digestion and 
deemed to be unique strains were brought forward for further subtrac-
tive screening. The majority of these comprised members of the Lb. 
casei/paracasei, Lb. curvatus and Lb. plantarum species, but also included 
Lb. helveticus, Lb. rhamnosus, Lb. coryniformis and a single S. thermophilus 
strain. These species are commonly associated with the NSLAB compo-
nent of Cheddar cheeses, although Lb. helveticus and S. thermophilus are 
often added intentionally as either starter LAB or adjunct cultures 
(Swearingen et al., 2001; Briggiler-Marcó, Capra, Quiberoni, Vinderola, 
Reinheimer, & Hynes, 2007; Fitzsimons, Cogan, Condon, & Beresford, 
2001; Peterson & Marshall, 2010). These results are in agreement with 
Sumeri, Adamberg, Uusna, Sarand, and Paalme (2012) who also re-
ported Lb. casei/paracasei strains being the most prominent members of 
the NSLAB population to survived simulated gastric transit; however, 
that study did not provide data on the overall proportion of the NSLAB 
population that survived this treatment or whether the surviving strains 
exhibited other probiotic characteristics. Additionally, many potential 
probiotics have previously been identified from the above species, 
although presence of beneficial probiotic traits have been cited as being 
heavily strain-dependant (Lebeer, Vanderleyden, & De Keersmaecker, 
2008). The number and species of individual strains capable of surviving 
SSDP differed between Cheddar cheeses. While most cheeses were 
observed to contain multiple strains capable of surviving SSDP, single 
strains were detected in three cheeses while up to twelve strains were 
observed in the cheeses containing the most diverse populations. Cheese 
7 contained the most variation in terms of species, including isolates of 
Lb. casei/paracasei, Lb. curvatus, Lb. helveticus and S. thermophilus. 
However, the majority of the cheeses (10 of the 12) contained strains 
from one or two species only. This is not unexpected as the cheeses used 
here had different sources, which will effect NSLAB content (Peterson & 
Marshall, 2010). High diversity of NSLAB can even be seen in cheeses 
manufactured in the same factory, as seen in a study in 2002 which 
determined that the number of NSLAB strains had high variability even 
when produced in the same milk vat during different time points, 
highlighting that NSLAB variability is very commonplace (Williams, 
Choi, & Banks, 2002). 
The ability of Lactobacillus to produce BSH enzymes has been docu-
mented by different groups, with high strain variability being observed 
(Begley et al., 2006; O’Flaherty, Briner Crawley, Theriot, & Barrangou, 
2018). Of the NSLAB selected by the initial screen, approximately 40% 
produced haloes of deconjugated bile when grown on MRS agar with 
0.3% cow bile. Various groups have identified beneficial Lb. plantarum 
strains with BSH activity, with evidence suggesting that expression of 
these enzymes aids persistence and adherence in the intestine (Kumar, 
Grover, & Batish, 2011; Lambert, Bongers, De Vos, & Kleerebezem, 
2008; Nguyen, Kang, & Lee, 2007; Patel, Singhania, Pandey, & Chin-
cholkar, 2010; Yang, Liu, Zhou, Huang, Chen, & Huan, 2019). The 
haloes produced by all Lb. plantarum strains were the largest, along with 
the positive Lb. reuteri strain. Seventeen of the thirty strains that pro-
duced deconjugated bile haloes were Lb. casei/paracasei strains, 
although their performance varied depending on previous incubation 
conditions. While less data exists of BSH positive Lb. casei/paracasei 
strains, certain groups have identified those capable of bile deconjuga-
tion such as the Lb. casei K17 identified in 2016 and eight Lb. paracasei 
strains in 2006 capable of at least partial hydrolysis of bile salts (Mar-
agkoudakis et al., 2006; Xu, Liu, Radji, Yang, & Chen, 2016). Similarly, a 
single Lb. rhamnosus and Lb. coryniformis strain displayed BSH activity. 
While the probiotic Lb. rhamnosus GG strain is capable of BSH produc-
tion, to date, there is no published data on a Lb. coryniformis strain 
capable of BSH expression, although there is an entry on UniProt for a 
Lb. coryniformis BSH protein (https://www.uniprot. 
org/uniprot/A0A1P8FCL4). 
Of the ten strains that failed the EFSA antibiotic susceptibility pro-
files, eight were resistant to Chloramphenicol. Genes primarily respon-
sible for Chloramphenicol resistance are cat (chloramphenicol 
acetyltransferase) genes which, when present in Lactobacillus, have 
typically been located on plasmids (Gueimonde, Sánchez, de los Reyes- 
Gavilán, & Margolles, 2013). This result is surprising as Lactobacillus are 
not traditionally associated with chloramphenicol resistance; however, 
this can vary between strains and several resistant strains have been 
identified previously from foods (Guo et al., 2017; Mathur & Singh, 
2005). In addition, six of the eight chloramphenicol-resistant strains also 
showed resistance to a second antibiotic, with four also showing growth 
in high concentrations of Tetracycline (the remaining two being capable 
of growth in Kanamycin). A paper published in 2019 examined 182 
Lactobacillus isolates selected in such a way as to represent all lactoba-
cilli species and found that 31% were resistant to both Chloramphenicol 
and Tetracycline (Campedelli et al., 2019). It is interesting to observe in 
both studies that chloramphenicol/tetracycline resistance was observed 
in some of the investigated species, as seen in this study for one Lb. casei/ 
Table 4 
General genomic features of Lb rhamnosus DPC7102 and Lb. paracasei DPC7150. 
*CDS, coding sequence (with protein).   
General Genomic Features of Lactobacillus 





BioSample Accession No. SAMN12280510 SAMN12280511 
No. of Contigs 131 280 
GC Content (%) 46.61 46.17 
Coverage (X) 149 44 
No. of CDS* 2978 2894 
ANI/OrthoANI 98.06/97.85 98.56/98.23 
Probability of being Human 
Pathogen (%) 
0.095 0.092  
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paracasei, two Lb. plantarum and one Lb. coryniformis strain. Kanamycin 
resistance was observed in three different Lb. casei/paracasei strains, 
with two showing dual resistance with Chloramphenicol. Lb. casei 
strains with dual resistance to Kanamycin and Chloramphenicol were 
also observed in Campedelli et al. (2019), with 10 of the 15 strains tested 
exhibiting the same dual resistance. Generally, aminoglycoside antibi-
otics are less efficient against gram positive anaerobes due to membrane 
impermeability characteristics associated with this group of bacteria 
(Elkins & Mullis, 2004). 
HT29-MTX cells produce both membrane-bound mucin proteins 
MUC1 and MUC3. While MUC1 is produced early on during differenti-
ation (Day 7) at their apical borders, MUC3 levels peak later (Day 14), 
with levels remaining consistent in both thereafter (Lesuffleur et al., 
1993; Mack, Ahrne, Hyde, Wei, & Hollingsworth, 2003) . More impor-
tantly, Days 7–14 of differentiation leads to a marked increase in 
expression of the MUC5 protein which is secreted and forms the pro-
tective gel/mucus layer of the intestinal tract and the initial foothold 
that allows potential adhesion of ingested microbes (Kleiveland, 2015; 
Santini et al., 2007) . As adherence varies greatly between strains, it was 
not surprising that the seven strains investigated here displayed adhe-
sion levels that ranged from 20 to 80%. Bacterial adhesion is an 
important trait for a potential probiotic as high adherence allows for 
extended residence times in the gut, during which time any host-specific 
benefits can take effect. Lb. rhamnosus DPC 7102 had the highest 
adhesion at 79.2%, with the positive control Lb. rhamnosus GG showing 
90.6% adhesion. Strain DPC 7102 was one of three strains that 
demonstrated high levels of adhesion that were not significantly 
different from that of the control strain, with the other two being Lb. 
paracasei DPC 7150 and Lb. casei/paracasei DPC 7087 which showed 
adherence values of 64.0 and 58.0, respectively. Lb. rhamnosus DPC 
7102 and Lb. paracasei DPC 7150 showed the highest adherence values 
of the seven strains tested and were, therefore, brought forward for 
additional testing. The other four strains tested showed significantly 
different and reduced adherence values when compared to the positive 
control strain and, thus, were not considered for further testing. 
Of the two strains tested for pathogen exclusion, Lb. rhamnosus DPC 
7102 was more efficient at excluding E. coli than Lb. paracasei DPC 7150 
(44.2% and 25.7% exclusion, respectively). These results support our 
observations in the adhesion assays which demonstrated that the Lb. 
rhamnosus strain was also capable of a higher level of adhesion, leaving 
less physical space and binding sites for pathogen adhesion once added, 
leading to greater exclusion of the pathogen. A member of the adhesive 
EPEC serotype was chosen for this assay. Once attached, they establish 
compact microcolonies which cause various morphological abnormal-
ities (including destruction of intestinal microvilli and blunt enterocyte 
borders) and cause diarrhoea (Fagundes-Neto & Scaletsky, 2000). 
Therefore, the ability of the NSLAB strains to inhibit adhesion of this 
pathogen highlights their potential as probiotics to protect against 
similar infectious agents. 
The ability of potential probiotic bacteria to produce EPS is desirable 
as EPS has associated commercial (as an emulsifying agent, improving 
mouthfeel and texture in dairy products) and health benefits (immu-
nomodulation, inhibition of pathogens and cholesterol-lowering capa-
bilities) (Liu et al., 2017). In this study, both Lb. rhamnosus DPC 7102 
and Lb. paracasei DPC 7150 exhibited white colony growth when 
streaked onto Ruthenium Red Skim Milk agar, along with the positive 
control Lb. casei/paracasei DPC 1116. This indicates that they are EPS 
producers as the generation of either capsular EPS or secreted EPS will 
prevent staining of the cell wall by the ruthenium red agent (Mora et al., 
2002). 
In an effort to confirm the species information obtained by 16S rRNA 
gene sequence analysis and to facilitate a more in depth analysis of the 
two organisms at the genetic level, with particular reference to the 
presence of additional antibiotic resistance genes or genes associated 
with virulence or human pathogens, whole genome sequencing and 
annotation was undertaken. This confirmed the species designations for 
both isolates but also further classified DPC7150 as Lb. paracasei. No 
genes associated with virulence were detected in either genome and 
neither organism is predicted to be a likely human pathogen. These are 
important observations with regard to the potential future use of either 
of these two strains as probiotics. 
5. Conclusion 
Of the 76 individual strains of NSLAB with gastric tolerance isolated, 
30 of them were also capable of BSH activity, which has been associated 
with cholesterol-lowering capabilities and indicates the potential health 
benefits of normal Cheddar cheese microbiomes. From these 30 BSH 
positive isolates, two Lactobacillus strains, DPC7102 and DPC 7150, were 
further demonstrated to display promising adhesion to and pathogen 
exclusion from a mammalian co-culture, are capable of EPS production, 
are also susceptible to antibiotics to an acceptable standard as set by the 
European Food Safety Authority and do not harbour any genes associ-
ated with virulence or human pathogenicity. These two strains are 
originally from Cheddar cheeses and could potentially be used as 
Adjunct Cultures in future cheese making. The added protection of the 
cheese matrix should ensure greater survival of lactobacilli cultures 
through the harsh gastric environment and into the small intestine, 
where the bacteria can then adhere and potentially exert their beneficial 
effects on the host. 
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